Harrison R. Bane - 04 Sep 2025 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Sep 2025, 16:29:17 UTC
Prior SEC filing
13 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jennifer Baldock, Attorney-in-Fact

Key filing fact

Harrison R. Bane filed Form 4 for Surgery Partners, Inc. (SGRY) on 08 Sep 2025.

Key facts

  • This page summarizes Harrison R. Bane's Form 4 filing for Surgery Partners, Inc. (SGRY).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Sep 2025, 16:29.

Change

  • Previous filing in this sequence was filed on 13 Mar 2025.
  • Current net transaction value: -$209,941.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001952229 Primary reporting owner

Bane Harrison R.

Relationship
National Group President
Address
C/O SURGERY PARTNERS, INC., 340 SEVEN SPRINGS WAY, SUITE 600, BRENTWOOD
Signature
/s/ Jennifer Baldock, Attorney-in-Fact
Signature date
08 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGRY transaction

Common Stock

Sale

Transaction value
$128,720
Shares
-5,726
Change %
-4.5%
Price
$22.48
Shares after
120,794
Date
04 Sep 2025
Ownership
Direct
Footnotes
F1
SGRY transaction

Common Stock

Sale

Transaction value
$81,220
Shares
-3,613
Change %
-3%
Price
$22.48
Shares after
117,181
Date
04 Sep 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on September 1, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .